Literature DB >> 769213

Cryptococcosis after renal transplantation: report of ten cases.

G P Schröter, D R Temple, B S Husberg, R Weil, T E Starzl.   

Abstract

Ten cases of cryptococcosis have been identified in a 13 year experience with more than 650 renal transplants. Eight patients had meningitis, one patient had a cerebral granuloma, and in one patient the infection appeared to be limited to the lungs. The central nervous system infection often masqueraded as brain tumor and was not suspected initially. The most useful diagnostic test was cerebrospinal fluid examination including India ink preparation. Various ther apeutic regimens with amphotericin B and 5-fluorocytosine were effective in suppressing the infection. A combination of low doses of amphotericin B, not affecting kidney function, with 5-fluorocytosine for at least 3 months was associated with remission of disease in five patients who still are alive, including three patients without recurrence for longer than one year. Five deaths 3 weeks to 4 years after the beginning of treatment were not due to cryptococcosis; death resulted from vascular disease and septiciemia in three of the four patients with known causes of death. Central nervous system cryptococcosis, with the exception of the rare cerebral granuloma, is associated with little inflammation. If early death from increased intracranial pressure or cerebral edema is prevented, prolonged therapy with amphotericin B and 5-fluorocytosine may be expected to control the infection, even in immunosuppressed patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 769213      PMCID: PMC2967188     

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  39 in total

1.  COCCIDIOIDOMYCOSIS AND AMPHOTERICIN B.

Authors:  W A WINN
Journal:  Med Clin North Am       Date:  1963-09       Impact factor: 5.456

2.  Pulmonary cryptococcosis: clinical forms and treatment. A Center for Disease Control cooperative mycoses study.

Authors:  K J Hammerman; K E Powell; C S Christianson; P M Huggin; H W Larsh; J R Vivas; F E Tosh
Journal:  Am Rev Respir Dis       Date:  1973-11

3.  Primary complex of Cryptococcus and pulmonary lymph nodes.

Authors:  W R Salyer; D C Salyer; R D Baker
Journal:  J Infect Dis       Date:  1974-07       Impact factor: 5.226

4.  Intracranial cryptococcal granuloma--amphotericin B and surgical excision.

Authors:  R Brisman; R Reid; G Harrington
Journal:  Surg Neurol       Date:  1973-01

Review 5.  Basic mechanisms of antifungal chemotherapy.

Authors:  E Drouhet
Journal:  Mod Treat       Date:  1970-05

6.  Amphotericin B in cryptococcal meningitis. Long-term results of treatment.

Authors:  G A Sarosi; J D Parker; I L Doto; F E Tosh
Journal:  Ann Intern Med       Date:  1969-12       Impact factor: 25.391

7.  A pharmacologic guide to the clinical use of amphotericin B.

Authors:  D D Bindschadler; J E Bennett
Journal:  J Infect Dis       Date:  1969-10       Impact factor: 5.226

8.  The spectrum of pulmonary cryptococcosis.

Authors:  W Warr; J H Bates; A Stone
Journal:  Ann Intern Med       Date:  1968-12       Impact factor: 25.391

9.  Cryptococcosis of the central nervous system. Epidemiological, clinical, and therapeutic features.

Authors:  V E Edwards; J M Sutherland; J H Tyrer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-08       Impact factor: 10.154

10.  Cryptococcus neoformans IV. The Not-So-Encapsulated Yeast.

Authors:  F Farhi; G S Bulmer; J R Tacker
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

View more
  16 in total

Review 1.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

2.  Cost and time savings following introduction of rejection criteria for clinical specimens.

Authors:  A J Morris; L K Smith; S Mirrett; L B Reller
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

Review 3.  Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.

Authors:  M T LaRocco; S J Burgert
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  Anticryptococcal activity by alveolar macrophages from rats treated with cortisone acetate during different periods of time.

Authors:  N T Gross; M Chinchilla; P Camner; C Jarstrand
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

5.  Influence of agglutinating antibody in experimental cryptococcal meningitis.

Authors:  J R Perfect; S D Lang; D T Durack
Journal:  Br J Exp Pathol       Date:  1981-12

6.  A microsomal fraction of Cryptococcus neoformans induces lymphocyte blastogenesis in infected guinea pigs.

Authors:  A E Jones; E Reiss; T J Spira
Journal:  Mycopathologia       Date:  1981-09-11       Impact factor: 2.574

7.  Fungus infections after liver transplantation.

Authors:  G P Schröter; M Hoelscher; C W Putnam; K A Porter; T E Starzl
Journal:  Ann Surg       Date:  1977-07       Impact factor: 12.969

8.  Cryptococcal sacroiliitis.

Authors:  C Brand; R Warren; M Luxton; D Barraclough
Journal:  Ann Rheum Dis       Date:  1985-02       Impact factor: 19.103

9.  Colonization and pathogenesis of Cryptococcus neoformans in gnotobiotic mice.

Authors:  C A Salkowski; K F Bartizal; M J Balish; E Balish
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

10.  Fungal infections in renal transplant recipients.

Authors:  R J Howard; R L Simmons; J S Najarian
Journal:  Ann Surg       Date:  1978-11       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.